-
公开(公告)号：DE2045407C3
公开(公告)日：1973-11-08
申请号：DE2045407
申请日：1970-09-15
Abstract: A navigational instrument for a ship incorporates an echo device arranged to measure the distance from a fixed part of the ship to the surface of the water at a point in advance of the ship. It includes a clinometer device arranged to measure the angle of fore and aft inclination of the ship from its static position and feed a corresponding signal to a computer together with the signal from the echo device. Indicating means receive the output from the computer which is in the form of an indication of the amount of the depression of the selected part of the ship and show such indication as a visual signal. The instrument may also incorporate a hog and sag clinometer providing a measure of any hog and sag present in the ship the output of said clinometer being also fed to the computer for correction of the output signal. The instrument may also incorporate means for feeding to the computer a signal which indicates the speed of the ship.
-
公开(公告)号：AU4933600A
公开(公告)日：2000-12-05
申请号：AU4933600
申请日：2000-05-15
Inventor： MOORE BARRY DOUGLAS , PARKER MARIE CLAIRE , HALLING PETER JAMES , PARTRIDGE JOANN
IPC: C12N9/96 , A61K9/14 , A61K31/7088 , A61K38/00 , A61K45/08 , A61K47/02 , A61K47/10 , A61K47/12 , A61K47/16 , A61K47/26 , A61K47/30 , A61K47/36 , C07K1/14 , C07K1/32 , C09D5/16 , C09D201/00 , C30B7/00 , G01Q90/00 , C07K1/00
Abstract: The present invention relates to protein-coated micro-crystals and their method of preparation. The protein-coated micro-crystals may find particular application in preparing enzymes for use as biocatalysts; preparation of therapeutic proteins for use in pharmaceutical formulations; production of cleansing agents comprising enzymes; production of paints, varnishes, coatings, films and the like comprising proteins which impart protective and/or antifouling properties; production of films, polymers, inks, coatings, electrodes and/or optical materials comprising proteins for diagnostic kits and/or biosensor applications; use of proteins for studies of molecular recognition, molecular binding and inhibitor binding in non-aqueous media; and preparation of protein based food additives.
-
公开(公告)号：AU4080493A
公开(公告)日：1993-12-13
申请号：AU4080493
申请日：1993-05-14
Inventor： SPIBEY NORMAN , JARRETT JAMES OSWALD
-
公开(公告)号：DE2737360B2
公开(公告)日：1979-06-13
申请号：DE2737360
申请日：1977-08-18
Inventor： HEMINGWAY, REGINALD GORDON , PARKINS, JAMES JOSEPH , FISHWICK, GRAHAM
-
公开(公告)号：GB201110729D0
公开(公告)日：2011-08-10
申请号：GB201110729
申请日：2011-06-24
Applicant: INVIBIO LTD , COURT OF THE UNIVERSITY OF GLASGOW THE
-
Patent Agency Ranking
公开(公告)号：AU4872099A
公开(公告)日：2000-06-08
申请号：AU4872099
申请日：1999-09-15
Inventor： MACLEAN ALASDAIR RODERICK , BROWN SUSANNE MOIRA , FRASER NIGEL WILLIAM , RANDAZZO BRUCE PAUL
IPC: A61K39/245
-
公开(公告)号：GB9415319D0
公开(公告)日：1994-09-21
申请号：GB9415319
申请日：1994-07-29
Applicant: MEDICAL RES COUNCIL , UNIV COURT UNIVERSITY OF GLASGOW
IPC: C12N15/09 , A61K38/27 , A61K38/45 , A61K39/00 , A61K48/00 , A61P25/00 , A61P25/28 , C12N7/04 , C12N15/869
Abstract: The present invention relates to a recombinant herpes simplex virus (HSV) viral vector genome which has substantially lost its transducing properties as a result of a DNA sequence change in the gene coding for Vmw65 protein and also comprises an expressable heterologous gene inserted into a region of the HSV genome which is non-essential for the culture of the virus, the gene being under the control of the immediate early (IE1) gene enhancer of cytomegalovirus (CMV) and to the use of the recombinant HSV genome in therapy and vaccination.
-
公开(公告)号：AU7075691A
公开(公告)日：1991-08-21
申请号：AU7075691
申请日：1991-01-25
Inventor： SPIBEY NORMAN
IPC: A61K39/235 , A61K39/00 , A61P31/12 , A61P31/20 , C07K14/075 , C07K14/145 , C12N7/00 , C12N15/09 , C12N15/45 , C12N15/861 , C12N15/86 , C12N15/35 , C12N15/47 , C12N15/48 , C12N15/50 , A61K39/295
Abstract: A recombinant adenovirus acting as a vector for an antigen-producing gene (e.g. a rabies glycoprotein gene) comprises a CAV-2 strain modified to contain the promoter-gene sequence within the region from the SmaI site close to the end of the inverted terminal repeat up to the promoter for the early region 4 (E4). To assist replication the recombinant virus is transfected into a cell line expressing Ela proteins. The recombinant virus is used for the production of a corresponding vaccine.
-
公开(公告)号：AU5768986A
公开(公告)日：1986-11-27
申请号：AU5768986
申请日：1986-05-22
Inventor： PARTON ROGER , STEWART-TULL DUNCAN ERIC STEWA
IPC: A61K39/095 , A61K39/00 , A61K39/10 , C07K14/235 , C07K15/12 , C07K3/28
Abstract: The present invention provides a method of preparing a substantially non-toxic immunogenia preparation of pertussis toxic comprising treatment of pertussis toxin with a cerbo- diimide. The preparation may be used for vaccination against whooping cough as well as making vaccines for use in immunisation against whooping cough. Desirably the pertussis toxin is treated in the form of an intimate admixture with filamentous.
-
公开(公告)号：DE2639192C3
公开(公告)日：1980-12-18
申请号：DE2639192
申请日：1976-08-31
-
-
-
-
-
-
-
-
-
Search Results
705
records
(took 0.027 seconds)
